𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Twenty Years’ Experience in Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome—Positive Acute Lymphoblastic Leukemia in the Nagoya Blood and Marrow Transplantation Group

✍ Scribed by Hiroatsu Iida; Hiroshi Sao; Kenjiro Kitaori; Seiichi Gotoh; Makoto Yazaki; Seiji Kojima; Atsushi Wakita; Yasuo Morishima; Yoshihisa Kodera; Yoshihisa Morishita

Publisher
Carden Jennings Publishing
Year
2004
Tongue
English
Weight
98 KB
Volume
79
Category
Article
ISSN
0925-5710

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Allogeneic bone marrow transplantation i
Allogeneic bone marrow transplantation in first remission rescues children with Philadelphia chromosome-positive acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) studies L89-12 and L92-13
✍ Mori, Taijiro ;Manabe, Atsushi ;Tsuchida, Masahiro ;Hanada, Ryoji ;Yabe, Hiromas 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

## Abstract ## Background The prognosis of Philadelphia chromosome‐positive acute lymphoblastic leukemia (Ph^+^ ALL) is generally poor and reports from large studies are scarce. We evaluated the efficacy of allogeneic bone marrow transplantation (allo‐BMT) for children with this type of leukemia.

The extent of minimal residual disease r
The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia
✍ Seok Lee; Yoo-Jin Kim; Nak-Gyun Chung; Jihyang Lim; Dong-Gun Lee; Hee-Je Kim; Ch 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 445 KB 👁 2 views

## Abstract ## BACKGROUND: Previously, the authors demonstrated the positive impact of imatinib on the outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome‐positive acute lymphoblastic leukemia (Ph‐positive ALL). Here, the authors analyzed for risk factors that af

Hematopoietic stem cell transplantation
Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia : Real-World Population-Based Data From the Swedish Acute Leukemia Registry 1997-2006
✍ Gunnar Juliusson; Karin Karlsson; Vladimir Lj Lazarevic; Anders Wahlin; Mats Bru 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 477 KB

## Abstract ## BACKGROUND: Allogeneic stem cell transplantation (alloSCT) reduces relapse rates in acute leukemia, but outcome is hampered by toxicity. Population‐based data avoid patient selection and may therefore substitute for lack of randomized trials. ## METHODS: We evaluated alloSCT rates